818GYN.com

Wait, what? The SF Valley is celebrating 818GYN.com

The San Fernando Valley Community Celebrates 818 Day! - Valley News Group The San Fernando Valley Community Celebrates 818 Day! by katie | Aug 19, 2021 | NewspaperIn celebration of the unique place this community calls home, Valley residents congregated at Westfield Fashion Square yesterday to celebrate the San Fernando Valley at “818 Day.” A valley-wide celebration o...

Nina Alcarez-Medical Assistant

I am Nina, and I am the back office Medical Assistant for Dr. Taras. I have been in the Medical field for 6 years. I assist Dr. Taras during all of his office exams and with all in office surgical procedures. I work hard to make sure all of our patients have a positive experience in our office and I enjoy seeing our patients walk out with a smile. After work I love spending time with my loved ones. I am honored and blessed to be part of the 818GYN family.

Chris Reyes-Front Office Manager

I’m Chris, the front office manager for Dr. Taras. I have been in the medical field as office support staff for the last 25 years. I am the voice you hear when you call our office. I have been blessed to work with this amazing staff and Dr. Taras for the past several years. My goal is to make sure our office is the right fit for your needs as well as making sure you are comfortable coming to your GYN office. When I am not with my office family and patients, I am enjoying time with my family. I have been married for 30+ years and we have 3 wonderful adult daughters and 3 happy, smart, beautiful and sassy grand-daughters.

Kelli Stephens-Accounts Manager

I’m Kelli, the behind the scenes person for Dr. Taras. I help navigate the very confusing process of insurance to best utilize your OON (out of network) benefits. I schedule and coordinate surgeries along with obtaining authorizations for specialty procedures and injectable medications.
I encourage you to reach out to me with any questions or problems regarding insurance or billing.
While not with my office family, you can bet I am with at least one or two of my FIVE grandsons! They are my reason to stay healthy and active.

This is my low-tech version of a privacy screen for my computer 🤦‍♂️

Is Pellet Therapy Right for You?
Click to watch this short video on EvexiPEL

https://evexias.kinsta.cloud/is-pellet-therapy-right-for-you

Alternatively go to www.tinyurl.com/818GYNEvexiPEL & we'll text you the video link!

Is Pellet Therapy Right for You? - Evexias Health Solutions Discover the difference EvexiPEL can make in your life. Thousands of patients just like you have changed their life with pellet therapy. Find out how — click to watch this short video or fill out the form and begin your journey to feeling your best now. Are you experiencing any of these symptoms? ...

Every time we insert a patient from EvexiPEL amongst many giants that we stand on the shoulders of, here are two: Dr. Neal Rouzier & Jenny Heafey. Thank YOU from the for

One down... many more to go! Thank you patient #1 (not sure why they call it patient zero) for stepping up to the plate and allowing us to post this after-procedure pic! Thank you for making the whole EvexiPEL process so smooth due in large part to Jenny Heafey!

Yesterday afternoon I 👨🏻‍⚕️ put in into TWO patients… EvexiPEL with Dr. Terri Suresh DeNeui put in over EIGHTY patients… just that same afternoon at EVEXIAS Medical Centers!!! Dan DeNeui you guys run an amazing 🤩 program! part of Team Jenny Heafey !

Every journey begins with the first step... sometimes also with a flight! Sometimes the for Nina!
EvexiPEL

Disgusting!

"Senior officials in the FBI Indianapolis Field Office failed to respond to allegations of s*xual abuse of athletes by former USA Gymnastics physician Lawrence Gerard Nassar with the urgency that the allegations required," the inspectors general's office said in a statement after the report was released Wednesday.

The Indianapolis officials didn't respond for eight months, according to the report. During the lag in the investigation, an attorney for survivors said Nassar molested at least 120 women and girls.

https://www.usatoday.com/story/news/politics/2021/07/14/feds-critical-fbi-delay-nassar-case/7970637002/

'Absolutely chilling': Larry Nassar s*x abuse reports met with massive FBI failures, DOJ watchdog says The FBI's roughly nine-month delay in investigating 2015 allegations has long been a point of contention for Nassar survivors.

EvexiPEL Hormone Balance Pellets - Taras Times - https://mailchi.mp/c0944ee27a3d/evexipel

EvexiPEL Testimonial feeling “10 years ago myself” Let me introduce you to one of the the EvexiPEL patients who will tell her story in 60 seconds.

Thank you for all those who came before us to make this possible!

Wishing everyone a happy and safe

We are neither recommending nor offering this ;)

Magnetic weight loss device that locks jaw almost shut created to 'fight global obesity epidemic' Seven women were only able to open their jaws 2mm wide for two weeks and were put on a reduced calorie, liquid-only diet.

Dr. Glen Mackenzie, (AKA: The guru of medical literature / AKA: Dr. 05255 / AKA: Women and Childrens Services of Southern Vermont) another conundrum for you... actually 3 questions:
(1) Is the data sufficient & solid for ?
(2) Why is this new pill SUPERIOR?
(3) If it is not superior, why would I choose it over decades old birth control pills?
https://www.empr.com/home/news/nextstellis-drospirenone-estetrol-pill-pregnancy-prevention/

Novel Oral Contraceptive Nextstellis Now Available - MPR Nextstellis, a novel combined oral contraceptive pill, is now available.

REASSURING: Incidence of invasive breast cancer in women treated with testosterone implants (PELLET): a prospective 10-year cohort study.

A sign of things to come?

Dr. Glen Mackenzie, the guru of reading medical publications... does this meet your sniff test?

Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study Background Testosterone implants have been used for over eighty years to treat symptoms of hormone deficiency in pre and postmenopausal women. Evidence supports that androgens are breast protective. However, there is a lack of data on the long-term effect of testosterone therapy on the incidence of....

Do you need a statin to lower your cholesterol? Chances are that your doctor will use this program to figure it out:
http://www.cvriskcalculator.com/
Before you start that Lipitor, etc., consider a trial of Red yeast rice capsules! Shhh secret! 🤫

ACC/AHA ASCVD Risk Calculator Calculate your risk for heart disease and stroke using the ASCVD algorithm published in the 2013 ACC/AHA guidelines.

Happy Birthday Kelli! 🎂
Hope you have a great day!
Here are some flowers because everyday you bring your smile in our office its like bringing flowers to work! 💐

Let me start by saying while I am HOPEFUL that this works I do NOT have confidence!

When the words "contentious decision" and "conflicting" stick out in a conversation, it does not give me scientific "warmth". Plus I remember a 60 minutes story on Alzheimers a few years ago that started out by showing some footage of a 60 minutes piece they had done 10 years prior with the same doctors. They then returned to those doctors who basically said, "remember what we told you 10 years ago? Yea, it was all wrong!" Just a dumb gynecologist here trying to read between the lines!

Here's what AMA (not my favorite source) wrote today: The Washington Post (6/7, A1, McGinley ) reports on Monday, the U.S. Food and Drug Administration “approved the first Alzheimer’s treatment intended to slow cognitive decline, a move hailed by patients and advocates but sharply criticized by others who argued there was not sufficient evidence that the drug works.” Aducanumab “is the first drug cleared for Alzheimer’s that is designed to alter the course of the disease by slowing the deterioration of brain function.” The FDA approved it “based on its ability to reduce clumps of amyloid beta in the brain,” but ordered Biogen “to conduct a post-approval study confirming the medicine actually slows cognitive deterioration.”

The New York Times (6/7, A1, Belluck , Robbins ) reports the approval was “a contentious decision, made despite opposition from the agency’s independent advisory committee and some Alzheimer’s experts who said there was not enough evidence that the drug can help patients.” The medication “is a monthly intravenous infusion.”

USA Today (6/7, Alltucker ) reports, “The FDA’s approval comes despite a contradictory recommendation from experts on the agency’s Peripheral and Central Nervous System Drugs Advisory Committee, which last November cited conflicting results from two main clinical trials.”

FDA approves new Alzheimer's drug, Aduhelm, the first in nearly two decades The FDA's landmark authorization of Biogen's Aduhelm requires the drug company to conduct a post-approval study to monitor its effectiveness.

- an injectable drug made by the pharmaceutical company Novo Nordisk, was approved Friday 6/4/21 by the Food and Drug Administration, for patients struggling with chronic obesity. Semaglutide was approved in 2019 by the FDA to treat Type 2 diabetes, sold under the brand name Ozempic, albeit at a lower dose. At the higher dose of 2.4 mg, the drug acts on centers in the brain to reduce appetite, leading to potentially significant weight loss when combined with increased physical activity, and counseling sessions with nutritionists to maintain a reduced-calorie diet. The once-a-week regimen made it easier to manage, unlike other anti-obesity medications, which need to be taken daily.

-For 68 weeks, participants injected themselves weekly with either semaglutide or a placebo. On average, over half of those who received the drug itself lost nearly 15% of their body weight, and over a third achieved a weight loss of at least 20% of their weight. Current anti-obesity drugs on the market result in a weight loss of about 6% to 12%.

-The company said it expects its price will be similar to that of its current anti-obesity medicine, Saxenda, which retails for $1,349.02 for a 30-day supply.

-A new generation of medications that harness the way the body normally regulates appetite, by using GLP-1 -- a naturally occurring hormone in the body that regulates appetite -- as a medication. "We naturally have signals from hormones in our body that cause us to be hungry, and when we eat, we feel full,"

-Currently, 42.4% of all adults in the U.S. suffer from obesity, defined as having a body mass index at or above 30, according to the Centers for Disease Control and Prevention. Given current trends, nearly 1 in 2 American adults will be obese by 2030, according to a 2019 study published in the New England Journal of Medicine.

Newly approved drug heralded as 'game changer' in the growing national obesity crisis The CDC says 42.4% of all adults in the United States suffer from obesity.

Pill shows benefit in certain hard-to-treat breast cancers:
LYNPARZA® (olaparib) reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial

Pill shows benefit in certain hard-to-treat breast cancers A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment in findings being reported early because they are so promising. Study results were released Thursday by the American Society of Clinical Oncology ahead of its annual meeting and publis...